Psychobiology of HIV Infection

Critical Reviews in Neurobiology

Volumn 11, Issue 4, 1997, Pages 289-321

  Cole, Steve W ^a,b   Kemeny, Margaret E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Psychology ^*  (United States)

Author keywords

CD4; Cortisol; Depression; Disease progression; HIV AIDS; HPA axis; Immune system; Neuroimmune interactions; Neuropeptides; Psychological factors; Psychoneuroimmunology; Stress; Sympathetic nervous system

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTONOMIC NERVOUS SYSTEM; DEPRESSION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; IMMUNOMODULATION; MENTAL STRESS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL SUPPORT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AUTONOMIC NERVOUS SYSTEM; DEPRESSION; DISEASE PROGRESSION; HIV-1; HUMANS; NEUROIMMUNOMODULATION; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 0030633175     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevneurobiol.v11.i4.30     Document Type: Article

References (241)

1. Munoz, A., Wang, M. C., Bass, S., Taylor, J. M., Kingsley, L. A., Chimel, J. S., et al., Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men, Multicenter AIDS Cohort Study Group, Am. J. Epidemiol., 130, 530, 1989.
2. Phair, J., Jacobson, L., Detels, R., Rinaldo, C., Saah, A., Schrager, L., et al., Acquired immune dificiency syndrome occurring within 5 years of infection with human immunodeficiency virus type 1: the Multicenter AIDS Cohort Study, J. Acquir. Immune Defic. Syndr., 5, 490, 1992.
3. Sheppard, H. W., Lang, W., Ascher, M. S., Vittinghoff, E., and Winkelstein, W., The characteristics of non-progressors: long term HIV-1 infection with stable CD4+ T-cell levels, AIDS, 7, 1159, 1993.
4. Levy, J. A., Pathogenisis of human immunodeficiency virus infection, Microbiol. Rev., 57, 183, 1993.
5. Koot, M., Keet, I. P., Vos, A. H., de Goede, R. E., Roos, M. T., Coutinho, R. A., et al., Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS, Ann. Intern. Med., 118, 681, 1993.
6. Haynes, B. F., Pantaleo, G., and Fauci, A. S., Toward an understanding of the correlates of protective immunity to HIV infection, Science, 271, 324, 1996.
7. Kaslow, R. A., Duquesnoy, R., VanRaden, M., Kingsley, L. Marrari, M., Friedman, H., et al., A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study, Lancet, 335, 927, 1990.
8. Munoz, A., Carey, V., Saah, A. J., Phair, J. P., Kingsley, L. A., Fahey, J. L., et al., Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus, J. Acquir. Immune Defic. Syndr., 1, 396, 1988.
9. Abrams, B., Duncan, D., and Hertz-Picciotto, I., A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men, J. Acquir. Immune Defic. Syndr., 6, 949, 1993.
10. Baum, M. K., Shor-Posner, G., Lu, Y., Rosner, B., Sauberlich, S. E., Fletcher, M. A., et al., Micronutrients and HIV-1 disease progression, AIDS, 9, 1051, 1995.
11. Guenter, P., Muurahainen, N., Simons, G., Kosok, A., Cohan, G. R., Rudenstein, R., and Turner, J. L., Relationships among nutritional status, disease progression, and survival in HIV infection, J. Acquir. Immune Defic. Syndr., 6, 1130, 1993.
12. Lusso, P. and Gallo, R. C., Human herpesvirus 6 in AIDS, Immunol. Today, 16, 67, 1995.
13. Webster, A., Lee, C. A., Cook, D. G., Grundy, J. E., Emery, V. C., Kernoff, P. B., et al., Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection, Lancet, 2, 63, 1989.
14. Bentwich, Z., Kalinkovich, A., and Weisman, Z., Immune activation is a dominant factor in the pathogenisis of African AIDS, Immunol. Today, 16, 187, 1995.
15. Ader, R., Cohen, N., and Felten, D., Psychoneuro-immunology: interactions between the nervous system and the immune system, Lancet, 345, 99, 1995.
16. Ader, R., Psychoneuroimmunology, Academic Press, Orlando, FL, 1981.
17. Ader, R., Felten, D. L., and Cohen, N., Psychoneuro-immunology, 2nd ed., Academic Press, San Diego, CA, 1991.
18. Blalock, J. E., The syntax of immune-neuroendocrine communication, Immunol. Today, 15, 504, 1994.
19. Ottaway, C. A. and Husband, A. J., The influence of neuroendocrine pathways on lymphocyte migration, Immunol. Today, 15, 511, 1994.
20. Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., and Weiss, R. A., The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature, 312, 763, 1984.
21. Ho, D. D., Rota, T. R., and Hirsch, M. S., Infection of monocyte/macrophages by human lymphotropic virus type III, J. Clin. Invest., 77, 1712, 1986.
22. Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A., HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor, Science, 272, 872, 1996.
23. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M., Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature, 373, 123, 1995.
24. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E., Deutsch, P., et al., Viral dynamics in human immunodeficiency virus type 1 infection, Nature, 373, 117, 1995.
25. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., and Ho, D. D., HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time, Science, 271, 1582, 1996.
26. Pantaleo, G., Graziosi, C., and Fauci, A. S., The immunopathogenesis of human immunodeficiency virus infection, N. Engl. J. Med., 328, 327, 1993.
27. Cossarizza, A., Ortolani, C., Mussini, C., Borghi, V., Guaraldi, G., Mongiardo, N., et al., Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome, J. Infect. Disease, 172, 105, 1995.
28. Pantaleo, G., Demarest, J. F., Soudeyns, H., Graziosi, C., Francois, D., Adelsberger, J. W., et al., Major expansion of CD8+ T cells with a predominant V-beta usage during the primary immune response to HIV, Nature, 370, 463, 1994.
29. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M, and Oldstone, M. B. A., Virus-specific CD8+ cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection, J. Virol., 68, 6103, 1994.
30. Levy, J. A., Mackewicz, C. E., and Barker, E., Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells, Immunol. Today, 17, 217, 1996.
31. Cooper, D. A., Gold, J., Maclean, P., Donovan, B., Finlayson, R., Barnes, T. G., et al., Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion, Lancet, i, 537, 1985.
32. Kaslow, P. A., Phair, J. P., Friedman, H. B., Lyter, D., Solomon, R. E., Dudley, J., et al., Infection with the human immunodeficiency virus: Clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study, Ann. Intern. Med., 107, 474, 1987.
33. Graziosi, C., Pantaleo, G., Butini, L., Demarest, J. F., Saag, M. S., Shaw, G. M., and Fauci, A. S., Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection, Proc. Natl. Acad. Sci. U.S.A., 90, 6405, 1993.
34. Pitak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K.-C., et al., High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR, Science, 249, 1749, 1993.
35. Phillips, A. N., Reduction of HIV concentration during acute infection: independence from a specific immune response, Science, 271, 497, 1996.
36. Detels, R., English, P. A., Giorgi, J. V., Visscher, B. R., Fahey, J. L., Taylor, J. M. G., et al., Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS, J. Acquir. Immune Defic. Syndr., 1, 390, 1988.
37. Lang, W., Perkins, H., Anderson, R. E., Royce, R., Jewell, N., and Winkelstein, W., Patterns of T lymphocyte changes with human immunodeficiency virus infection: From seroconversion to the development of AIDS, J. Acquir. Immune Defic. Syndr., 2, 63, 1989.
38. Margolick, J. B., Donnenberg, A. D., Munoz, A., Park, L. P., Bauer, K. D., Giorgi, J. V., et al., Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes, J. Acquir. Immune Defic. Syndr., 6, 153, 1993.
39. Centers for Disease Control, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR, 41(RR-17), 1, 1992.
40. Embertson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., and Haase, A. T., Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS, Nature, 362, 359, 1993.
41. Pantaleo, G., Craziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., et al., HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease, Nature, 362, 355, 1993.
42. Frost, S. D. W. and McLean, A. R., Germinal center destruction as a major pathway in HIV pathogenesis, J. Acquir. Immune Defic. Syndr., 7, 236, 1994.
43. Heeney, J. L., AIDS: A disease of impaired Th cell renewal? Immunol. Today, 16, 515, 1995.
44. Helbert, M. R., L'age-Stehr, J., and Mitchison, N. A., Antigen presentation, loss of immunologic memory, and AIDS, Immunol. Today, 14, 340, 1993.
45. Cohen, J. A. and Laudenslager, M., Autonomic nervous system involvement in patients with human immunodeficiency virus infection, Neurology, 39, 1111, 1989.
46. Kumar, M., Morgan, R., Szapocznik, J., and Eisdorfer, C., Norepinephrine response in early HIV infection, J. Acquir. Immune Defic. Syndr., 4, 782, 1991.
47. Villette, J. M., Bourin, P., Doinel, C., Mansour, I., Fiet, J., Boudou, P., et al., Circadian variation in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with the human immunodeficiency virus, J. Clin. Endocrinol. Metab., 70, 572, 1990.
48. Membrino, L., Irony, I., Dere, W., Klein, R., Biglieri, E. G., and Cobb, E., Adrenocortical function in acquired immunodeficiency syndrome, J. Clin. Endocrinol. Metab., 65, 482, 1987.
49. Merinich, J. A., McDermott, M. T., Asp, A. A., Harrison, S. M., and Kidd, G. S., Evidence of endocrine involvement early in the course of Human Immunodeficiency Virus infection, J. Clin. Endocrinol. and Metab., 70, 566, 1993.
50. Grinspoon, S. K. and Bilezikian, J. P., HIV disease and the endocrine system, N. Engl. J. Med., 327, 1360, 1992.
51. Heaton, R. K., Velin, R. A., McCutchan, J. A., Gulevich, S. J., Atkinson, J. H., Wallace, M. R., et al., Neuropsychological impairment in human immunodeficiency virus infection: Implications for employment, Psychosom. Med., 56, 8, 1994.
52. Price, R. W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A. C., and Cleary, P., The brain and AIDS: central nervous system HIV-1 infection and AIDS dementia complex, Science, 239, 586, 1988.
53. Norman, S. E., Chediak, A. D., Freeman, C., Kiel, M., Mendez, A., Duncan, R., et al., Sleep disturbance in men with asymptomatic human immunodeficiency virus (HIV) infection, Sleep, 15, 150, 1992.
54. Fan, J., Bass, H. Z., and Fahey, J. L., Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection, J. Immunol., 151, 5031, 1993.
55. Von Sydow, M., Sonnerborg, A., Gaines, H., and Strannegard, O., Interferon-alpha and tumor necrosis factor alpha in serum of patients in various stages of HIV-1 infection, AIDS Res. Hum. Retroviruses, 7, 375, 1991.
56. Scott-Algara, D., Vuillier, F., Marasescu, M., De Saint Martin, J., and Dighiero, G., Serum levels of IL-2, IL-l-a, TNF-a, and soluble receptor of IL-2 in HIV-1 infected patients, AIDS Res. Hum. Retroviruses, 7, 381, 1991.
57. Nakajima, K., Martinez-Maza, O., Hirano, T., Breen, E. C., Nishanian, P. G., Salazar-Gonzalez, F., Fahey, J. L., and Kishimoto, T., Induction of IL-6 (B cell stimulatory factor-2/IFN-beta2) production by HIV, J. Immunol., 142, 531, 1989.
58. Israel-Biet, D., Cadranel, J., Beldjord, K., Andrieu, J. M., Jeffrey, A., and Even, P., Tumor necrosis factor production in HIV-seropositive subjects, J. Immunol., 147, 490, 1991.
59. Clerici, M., Hakim, F. T., Venzon, D. J., Blatt, S., Hendrix, C., Wynn, T. A., and Shearer, G. M., Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals, J. Clin. Invest., 91, 759, 1993.
60. Balter, M., Cytokines move from the margins into the spotlight, Science, 268, 205, 1996.
61. Ullum, H., Palmo, J., Halkjer, Kristenson, J., Diamant, M., Klokker, M., Kruuse, A., et al., The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive persons, J. Acquir. Immune Deflc. Syndr., 7, 1122, 1994.
62. Mosier, D. E., Gulizia, R. J., Maclsaac, P. D., Torbett, B. E., and Levy, J. A., Rapid loss of CD4+ T cells in Human-PBL-SCID mice by noncytopathic HIV isolates, Science, 260, 689, 1993.
63. Nowak, M. A., May, R. M., Phillips, R. E.f, Rowland-Jones, S., Lalloo, D., McAdam, S., et al., Antigenic oscillations and the shifting immunodominance in HIV-1 infections, Nature, 375, 606, 1995.
64. Wolinsky, S. M., Korber, B. T. M., Neumann, A. U., Daniels, M., Kunstman, K. J., Whetsell, A. J., et al., Adaptive evolution of human immunodeficiency virus type-1 during the natural course of infection, Science, 272, 537, 1996.
65. Coffin, J. M., HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy, Science, 267, 483, 1995.
66. Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P., and Phalguni, G., Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion, Ann. Intern. Med., 122, 573, 1995.
67. Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., and Kingsley, L. A., Prognosis in HIV-1 infection predicted by the quantity of virus in plasma, Science, 272, 1167, 1996.
68. Ho, D. D., Viral counts count in HIV infection, Science, 272, 1124, 1996.
69. O'Brien, W. A., Grovit-Ferbas, K, Namazi, A., Ovcak-Derzics, S., Wang, H. J., Park, J., et al., Human immunodeficiency virus type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination, Blood, 86, 1082, 1995.
70. Fauci, A. S., Multifactorial nature of human immunodeficiency virus disease: Implications for therapy, Science, 265, 248, 1994.
71. Fahey, J. L., Taylor, J. M. G., Detels, R., Hofmann, B., Melmed, R., Nishanian, P., and Giorgi, J. V., The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1, N. Engl. J. Med., 322, 166, 1990.
72. Saah, A. J., Hoover, D. R., He, Y., Kingsley, L. A., Phair, J. P., and the Multicenter AIDS Cohort Study, Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS), J. Acquir. Immune Defic. Syndr., 1, 287, 1994.
73. Phillips, A. N., Lee, C. A., Webster, A., Janossy, G., Timms, A., Bofill, M. and Kernoff, P. B., More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts, J. AIDS, 4, 970, 1991.
74. Melnick, S. L., Sherer, R., Louis, T. A., Hillman, D., Rodriguez, E. M., Lackman, C., et al., Survival and disease progression according to the gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS, JAMA, 272, 1915, 1994.
75. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper J, Knowles, D. M., and Moore, P. S., Identification of herpesvirus-like DNA sequences in AIDS associated Kaposi's sarcoma, Science, 266, 1865, 1994.
76. Weiner, H., Perturbing the Organism: The Biology of Stressful Experience, University of Chicago Press, Chicago, 1992.
77. Rose, R. M., Endocrine responses to stressful psychological events, Psychiat. Clin. North Am., 3, 251, 1980.
78. Lundberg, U. and Frankenhauser, M., Pituitary-adrenal and sympathetic-adrenal correlates of distress and effort, J. Psychosom. Res., 24, 125, 1980.
79. Chrousos, G. P. and Gold, P. W., The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis, JAMA, 267, 1244, 1992.
80. Brown, R. E., An Introduction to Neuroendocrinology, Cambridge University Press, New York, 1992.
81. Pert, C. B., Ruff, M. R., Weber, R. J., and Herkenham, M., Neuropeptides and their receptors: a psychosomatic network, J. Immunol., 135, 820s, 1985.
82. Heinjen, C. J., Kavelaars, A., and Bellieux, R. E., Corticotropin-releasing hormone and proopiomenalo-cortin-derived peptides in the modulation of immune function, in Psychoneuroimmunology, Ader, R., Felten, D. L., and Cohen, N., Eds., Academic Press, San Diego, 1991.
83. Claman, H. N., Corticosteroids and the immune response, Adv. Exp. Med. Biol., 245, 203, 1988.
84. Glaser, R., Pearl, D. K., Kiecolt-Glaser, J. K., and Malarkey, W. B., Plasma cortisol levels and reactivation of latent Epstein-Barr virus in response to examination stress, Psychoneuroendocrinology, 19, 765, 1994.
85. Kirschbaum, C. and Hellhammer, D. K., Salivary cortisol in psychobiological research, Neuropsychobiology, 22, 150, 1989.
86. Schedlowski, M., Jacobs, R., Stratman, G., Richter, S., Hadicke, A., Tewes, U., et al., Changes of natural killer cells during acute psychological stress, J. Clin. Immunol., 13, 119, 1993.
87. Weitzman, E. D., Fukushima, D., Nogeire, S., Roffwarg, H., Gallagher, T. F., and Hellman, L., Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects, J. Clin. Endocrinol. and Metab., 33, 14, 1971.
88. Levi, F. A., Canon, C., Touitou, Y., Sulon, J., Mechkouri, M., Ponsart, E. D., et al., Circadian rhythms in circulating T lymphocyte subsets and plasma testosterone, total and free cortisol in five healthy men, Clin. Exp. Immunol., 71, 329, 1988.
89. Hohagen, F., Timmer, J., Weyerbrock, A., Fritsch-Montero, R., Ganter, U., et al., Cytokine production during sleep and wakefulness and its relationship to cortisol in healthy humans, Neuropsychobiology, 28, 9, 1993.
90. Cupps, T. R. and Fauci, A. S., Corticosteroid-mediated immunoregulation in man, Immunol. Rev., 65, 133, 1982.
91. Munck, A. and Guyre, P. M., Glucocorticoids and immune function, in Psychoneuroimmunology, Ader, R., Felten, D. L., and Cohen, N., Eds., Academic Press, San Diego, 1991.
92. Neifeld, J. P., Lippman, M. E., and Tormey, D. C., Steroid hormone receptors in normal human lymphocytes, J. Biol. Chem., 252, 2972, 1977.
93. McConkey, D. J., Hartzell, P., Nocotera, P., and Orrenius, S., Calcium-activated DNA fragmentation kills immature thymocytes, FASEB J., 3, 1843, 1989.
94. Daynes, R. A. and Araneo, B. A., Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4, Eur. J. Immunol., 19, 2319, 1989.
95. Rook, G. A. W., Hernandez-Pando, R., and Lightman, S. L., Hormones, peripherally activated prohormones and the regulation of the Th1/Th2 balance, Immunol. Today, 15, 301, 1994.
96. Chiappelli, F., Manfrini, E., Francheschi, C., Cossarizza, A., and Black, K. L., Steroid regulation of cytokines: Relevance for TH1-to-TH2 shift? Ann. N.Y. Acad. Sci., 746, 204, 1994.
97. Auphan, N., Didonato, J. A., Rosette, C., Helmberg, A., and Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-kB activity through induction of IKB synthesis, Science, 270, 286, 1995.
98. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., and Baldwin, A. S., Role of transcriptional activation of IKBα in mediation of immunosuppression by glucocorticoids, Science, 270, 283, 1995.
99. Munck, A., Guyer, P. M., and Holbrook, N. Y., Physiological functions of glucocorticoids in stress and their relation to pharmacological actions, Endocr. Rev., 5, 25, 1984.
100. Besedovsky, H. O. and Sorkin, E., Network of immune-neuroendocrine interactions, Clin. Exp. Immunol., 27, 1, 1977.
101. DeRijk, R. and Berkenbosch, F., Suppressive and permissive actions of glucocorticoids: a way to control innate immunity and to facilitate specificity of adaptive immunity? In Bilateral Communication Between the Endocrine and Immune Systems, Grossman, C. J., Ed., Springer Verlag, New York, 1994, 73.
102. Chiapelli, F., Yamashita, N., Faisal, M., Kemeny, M., Bullington, R., Nguyen, L., et al., Differential effect of beta-endorphin on three human cytotoxic cell populations, Int. J. Immunopharmocol., 13, 291, 1991.
103. Shavit, Y., Terman, G. W., Martin, F. C., Lewis, J. W., Liebeskind, J. C., and Gale, R. P., Stress, opioid peptides, the immune system, and cancer, J. Immunol., 135, 834s, 1985.
104. Berczi, I., Hormonal interactions between the pituitary and immune systems, in Bilateral Communication Between the Endocrine and Immune Systems, Grossman, C. J., Ed., Springer Verlag, New York, 1994, 98.
105. Markham, P. D., Salahuddin, S. Z., Veren, K., Orndorff, S., and Gallo, R. C., Hydrocortisone and some other hormones enhance the expression of HTLV-III, Int. J. Cancer, 37, 67, 1986.
106. Hofmann, B., Nishanian, P., Fahey, J. L., Esmail, I., Jackson, A. L., Detels, R., and Cumberland, W., Serum increases and lymphoid cell surface losses of IL2 receptor CD25 in HIV infection: distinctive patterns of HIV-induced change, Clin. Immunol. Immunopathol., 61, 212, 1991.
107. Clerici, M. and Shearer, G. M., A TH1->TH2 shift is a critical step in the etiology of HIV infection, Immunol. Today, 14, 107, 1993.
108. Clerici, M. and Shearer, G. M., The Th1-Th2 hypothesis of HIV infection: new insights, Immunol. Today, 15, 575, 1994.
109. Mosmann, T. R., Cytokine patterns during the progression to AIDS, Science, 265, 193, 1994.
110. Maggi, E., Mazzetti, M., Ravina, A., Annunziato, F., De Carli, M., Piccinni, M. P., et al., Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells, Science, 265, 244, 1994.
111. Graziosi, C., Pantaleo, G., Gantt, K. R., Fortin J.-P., Demarest, J. F., Cohen, O. J., et al., Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals, Science, 265, 248, 1994.
112. Kertzner, R. M., Goetz, R., Todak, G., Cooper, T., Lin, S. H., Reddy, M. K., et al., Cortisol levels, immune status, and mood in homosexual men with and without HIV infection, Am. J. Psychiatry, 150, 1674, 1993.
113. Gorman, J. M., Kertzner, R., Cooper, T., Goetz, R. R., Lagomasino, I., Novacenko, H., et al., Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection, Am. J. Psychiatry, 41, 148, 1991.
114. Croxson, T. S., Chapman, W. E., Miller, L. K., Levit, C. D., Senie, R., and Zumoff, B., Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men, J. Clin. Endocrinol. Metab., 68, 317, 1989.
115. Gorman, J. M., Warne, P. A., Begg, M. D., Cooper, T. B., Novacenko, H., Williams, J. B., et al., Serum prolactin levels in homosexual and bisexual men with HIV infection, Am. J. Psychiatry, 49, 367, 1992.
116. Wagner, G., Rabkin, J. G., and Rabkin, R., Illness stage, concurrent medications and other correlates of low testosterone in .men with HIV illness, J. Acquir. Immune Defic. Syndr., 8, 204, 1995.
117. Frankenhauser, M., Experimental approaches to the study of catecholamines and emotion, in Emotions -Their Parameters and Measurement, Levi, L., Ed., Raven Press, New York, 1975.
118. Ward, M. M., Mefford, I. N., Parker, S. D., Chesney, M. A., Taylor, C. B., Keegan, D. L., and Barchas, J. D., Epinephrine and norepinephrine responses in continuously collected human plasma to a series of Stressors, Psychosom. Med., 45, 471, 1983.
119. Loewy, A. D. and Spyer, K. M., Central Regulation of Autonomic Functions, Oxford University Press, New York, 1990.
120. Dimsdale, J. E. and Moss, J., Plasma catecholamines in stress and exercise, JAMA, 243, 340, 1980.
121. Cryer, P. E., Physiology and pathophysiology of the human sympathodrenal neuroendocrine system, N. Engl. J. Med., 303, 436, 1980.
122. Felten, D. L., Felten, S. Y., Bellinger, D. L., Carlson, S. L., Ackerman, K. D., Madden, K. S., et al., Noradrenergic sympathetic neural interactions with the nervous system: structure and function, Immunol. Rev., 100, 225, 1987.
123. Landmann, R., Beta-adrenergic receptors in human leukocyte subpopulations, Eur. J. Clin. Invest., 22, S1-30, 1993.
124. Ottaway, C. A. and Husband, A. J., Central nervous system influences on lymphocyte migration, Brain Behav. Immunity, 6, 97, 1992.
125. Benschop, R. J., Niewenhuis, E. E., Tromp, E. A., Godaert, G. L., Ballieux, R. E., and vanDoornen, L. J., Effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress, Circulation, 89, 762, 1994.
126. Novak, T. J. and Rothenberg, E. V., cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells, Proc. Nat. Acad. Sci. U.S.A., 87, 9353, 1990.
127. Gan, X. and Bonavida, B., Selective inhibition of Th1-type cytokines derived from human peripheral blood mononuclear cells and its subpopulations by the sympathetic neurotransmitter norepinephrine, abstract presented at the 1996 Scientific Conference of the Psychoneuroimmunology Research Society, Santa Monica, CA.
128. Ramer-Quinn, D. S., Baker, R. A., and Sanders, V. M., Functional heterogeneity between Th1 and Th2 cells exposed to a beta-2-adrenergic receptor agonist (B2AR) is due to restricted B2AR expression by Th1 cells, abstract presented to 1996 Scientific Conference of the Psychoneuroimmunology Research Society, Santa Monica, CA.
129. Sanders, V. M. and Munson, A. E., Norepinephrine and the antibody response, Pharmocol. Rev., 37, 229, 1985.
130. Koff, W. C. and Dunegan, M. A., Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells, J. Immunol., 136, 705, 1986.
131. Heilig, M., Irwin, M., Grewal, I., and Sercarz, E., Sympathetic regulation of T-helper cell function, Brain Behav. Immunity, 7, 154, 1993.
132. Strom, T. B., Carpenter, C. B., Garovoy, M. R., Austen, K. F., Merrill, J. P., and Kaliner, M., The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity, J. Exp. Med, 138, 381, 1974.
133. Bourne, H. R., Lichtenstein, L. M., Melmon, K. L., Henney, C. S., Weinstein, Y., and Shearer, G. M., Modulation of inflammation and immunity by cyclic AMP, Science, 184, 19, 1974.
134. Herbert, T. B. and Cohen, S., Stress and immunity in humans: a meta-analytic review, Psychosom. Med., 55, 364, 1993.
135. Herbert, T. B., Cohen, S., Marsland, A. L., Bachen, E. A., Rabin, B. S., Muldoon, M. F., and Manuck, S. B., Cardiovascular reactivity and the course of immune response to an acute psychological Stressor, Psychosom. Med., 56, 337, 1993.
136. Cacioppo, J. T., Malarkey, W. B., Kiecolt-Glaser, J. K., Uchino, B. N., Sgoutas-Emch, S. A., Sheridan, J. F., et al., Heterogeneity in neuroendocrine and immune responses to brief psychological Stressors as a function of autonomic cardiac activation, Psychosom. Med., 57, 154, 1995.
137. Naliboff, B. D., Solomon, G. F., Gilmore, S., Fahey, J. L., Benton, D., and Pine, J., Rapid changes in cellular immunity following a confrontational role-play Stressor, Brain Behav. Immunity, 9 207, 1995.
138. Bachen, E. A., Manuck, S. B., Cohen, S., Muldoon, M. F., Raible, R., Herbert T. B., and Rabin, B. S., Adrenergic blockade ameliorates cellular immune responses to mental stress in humans, Psychosom. Med., 57, 336, 1995.
139. Benschop, R. J., Brosschot, J. F., Godaert, G. L., DeSmet, M. B., Geenen, R., Olff, M., et al., Chronic stress affects immune but not cardiovascular responsiveness to acute psychological stress, Am. J. Physiol., 266, R75, 1994.
140. Dobbs, C. M., Vasquez, M., Glaser, R., and Sheridan, J. F., Mechanisms of stress-induced modulation of viral pathogenesis and immunity, J. Neuroimmunol., 48, 151, 1993.
141. Lyte, M., The role of microbial endocrinology in infectious disease, J. Endocrinol., 137, 343, 1993.
142. Lacey, J. I. and Lacey, B. C., The law of initial value in the longitudinal study of autonomic consitution: reproducibility of autonomic responses and response patterns over a four-year interval, Ann. N.Y. Acad. Sci., 98, 1257, 1962.
143. Fahrenberg, J. Schneider, H.-J., and Saflan, P., Psychophysiological assessments in a repeated-measurement design extending over a one-year interval: trends and stability, Biol. Psychol., 24, 49, 1987.
144. Marsland, A. L., Manuck, S. B., Fazzari, T. V., Stewart, C. J., and Rabin, B. S., Stability of individual differences in cellular immune response to acute stress, Psychosom. Med., 57, 295, 1995.
145. Nokta, M. A. and Pollard, R. B., Human immunodeficiency virus replication: modulation by cellular levels of cAMP, AIDS Res. Hum. Retroviruses, 8, 1255, 1992.
146. Hofmann, B., Nishanian, P., Nguyen, T., Liu, M., and Fahey J., Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues, AIDS, 7 659, 1993.
147. Fox, C. H. and Cottler-Fox, M., The pathobiology of HIV infection, Immunol. Today, 13, 353, 1992.
148. Helbert, M. R., L'age-Stehr, J., and Mitchison, N. A., Antigen presentation, loss of immunological" memory and AIDS, Immunol. Today, 13, 340, 1993.
149. Glaser, R. and Kiecolt-Glaser, J., Stress-associated depression in cellular immunity: implications for acquired immune deficiency syndrome, Brain Behav. Immunity, 1, 107, 1987.
150. Rosenberg, Z. and Fauci, A. S., Mini-review: induction of expression of HIV in latently or chronically infected cells, AIDS Res. Hum. Retroviruses, 5, 1, 1989.
151. Glaser, R., Pearson, G. R., Jones, J. F., Hillhouse, J., Kennedy, S., Mao, H. Y., and Kiecolt-Glaser, J. K., Stress-related activation of Epstein-Barr virus, Brain Behav. Immunity, 5, 219, 1991.
152. Glaser, R., Kiecolt-Glaser, J. K., Speicher, C. E., and Holliday, J. E., Stress, loneliness, and changes in herpesvirus latency, J. Behav. Med., 8, 249, 1985.
153. Esterling, B. A., Antoni, M. H., Schneiderman, N., Carver, C. S., La Perriere, A., Ironson, G., Klimas, N., and Fletcher, M. A., Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and human herpesvirus type-6 in HIV-1 infected and at risk gay men, Psychosom. Med., 54, 354, 1992.
154. Elliott, G. R. and Eisdorfer, C., Stress and Human Health, Springer, New York, 1982.
155. Mason, J. W., Emotion as reflected in patterns of endocrine integration, in Emotions - Their Parameters and Measurement, Levi, L., Ed., Raven Press, New York, 1975.
156. Sapolsky, R. M., Why Zebras Don't Get Ulcers: A Guide to Stress, Stress-Related Disease, and Coping, W. H. Freeman and Company, New York, 1993.
157. Kessler, R. C., Foster, C., Joseph, J., Ostrow, D., Wortman, C., Phair, J., et al., Stressful life events and symptom onset in HIV infection, Am. J. Psychiatry, 148, 733, 1991.
158. Perry, S., Fishman, B., Jacobsberg, L., and Frances, A., Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus, Arch. Gen. Psychiatry, 49, 396, 1992.
159. Rabkin, J., Williams, J. B. W., Remien, R. H., Goetz, R., Kertzner, R., and German, J. M., Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men, Arch, Gen. Psychiatry, 48, 111, 1991.
160. Goodkin, K., Fuchs, I., Feaster, D., Leeka, J., and Rishel, D., Life Stressors and coping style are associated with immune measures in HIV-1 infection - a preliminary report, Int. J. Psychiat. Med., 22, 155, 1992.
161. Evans, D., L., Leserman, J., Perkins, D. O., Stern, R. A., Murphy, C., Tamul, K., et al., Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection, Am. J. Psychiatry, 152, 543, 1995.
162. Martin, J. L., Psychological consequences of AIDS-related bereavement among gay men, J. Consult. Clin. Psychol., 56, 856, 1988.
163. Martin, J. L. and Dean, L., Effects of AIDS-related bereavement and HIV-related illness on psychological distress among gay men: a seven-year longitudinal study (1985-1992), J. Consult. Clin. Psychol., 61, 94, 1993.
164. Bartrop, R. W., Luckhurst, E., Lazarul, L., Kiloh, L. G., and Penny, R., Depressed lympnocyte function after bereavement, Lancet, 1, 834, 1977.
165. Schleifer, S. J., Keller, S. E., Camerino, M., Thronton, J. C., and Stein, M., Suppression of lymphocyte stimulation following bereavement, JAMA, 240, 374, 1983.
166. Irwin, M., Daniels, M., Smith, T., Bloom, E., and Weiner, H., Impaired natural killer cell activity during bereavement, Brain Behav. Immunity, 1, 98, 1987.
167. Stroebe, M. S. and Stroebe, W., Who suffers more? Sex differences in health risks of the widowed, Psychol. Bull, 93, 297, 1983.
168. Kemeny, M. E., Weiner, H., Taylor, S. E., Schneider, S., Visscher, B., and Fahey, J. L., Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men, Health Psychol., 13, 14, 1994.
169. Kemeny, M. E., Weiner, H., Duran, R., Taylor, S. E., Visscher, B., and Fahey, J. L., Immune system changes following the death of a partner in HIV positive gay men, Psychosom. Med., 57, 547, 1995.
170. Kemeny, M. E. and Dean, L., Effects of AIDS-related bereavement on HIV progression among New York City gay men, AIDS Ed. Prev., 7, 36s, 1995.
171. Segerstrom, S., Taylor, S. E., Kemeny, M. E., Reed, G., and Visscher, B. R., Causal attributions predict rate of immune decline in HIV seropositive gay men, Health Psychol., 15, 485, 1996.
172. Bower, J. E., Kemeny, M. E., Taylor, S. E., and Fahey, J. L., Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV seropositive gay men (under review).
173. Neugebaur, R., Rabkin, J. G., Williams, J. B., Reimen, R. H., Goetz, R., and Gorman, J. M., Bereavement reactions among homosexual men experiencing multiple losses in the AIDS epidemic, Am. J. Psychiat., 149, 1374, 1992.
174. Greer, S., Morriss, T., Pettingale, K. W., and Haybittle, J. L., Psychological response to cancer and 15 year outcome, Lancet, i, 49, 1990.
175. Fawzy, F. I., Fawzy, N. W., Hyun, C. S., Elashoff, R., Guthrie, D., Fahey, J. L., and Morton, D. L., Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later, Arch. Gen. Psychiatry, 50, 681, 1993.
176. Spiegel, D., Bloom, R. J., Kraemer, H. C., and Gottheil, E., Effect of psychosocial treatment on survival of patients with metastatic breast cancer, Lancet, ii, 888, 1989.
177. Goodkin, K., Blaney, N. T., Feaster, D., Fletcher, M. A., Baum, M. K., Mantero-Atienza, E., et al., Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HlV-1 seropositive homosexual men, J. Psychosom. Res., 36, 635, 1990.
178. Solano, L., Costa, M., Salvati, S., Coda, R., Aiuti, F., Mezzaroma, I., and Bertini, M., Psychosocial factors and clinical evolution in HIV-1 infection: a longitudinal study, J. Psychosom. Res., 37, 39, 1993.
179. Reed, G. M., Kemeny, M. E., Taylor, S. E., Wang, H.-Y. J., and Visscher, B. R., Realistic acceptance as a predictor of decreased survival time in gay men with AIDS, Health Psychol., 13, 299, 1994.
180. Reed, G. M., Kemeny, M. E., Taylor, S. E., and Visscher, B. R., Negative HIV-specific expectancies and AIDS-related bereavement as predictors of symptom onset in asymptomatic HIV seropositive gay men, Health Psychol., in press.
181. Kemeny, M. E., Reed, G. M., Taylor, S. E., Visscher, B. R., and Fahey, J. L., Negative HIV-specific expectancies predict immunological evidence of HIV progression (under review).
182. Ironson, G., Friedman, A., Klimas, N., Antoni, M., Fletcher, M. A., LaPerriere, A., Simoneau, J., and Schneiderman, N., Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus, Int. J. Behav. Med., 1994, 1, 90.
183. Coates, T. J., McKusick, L., Knuo, R., and Stites, D. P., Stress reduction training changed number of sexual partners but not immune function in men with HIV, Am. J. Publ. Health, 79, 885, 1989.
184. Eller, L. S., Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV, Ann. Behav. Med., 17, 339, 1995.
185. Taylor, D. N., Effects of a behavioral stress-management program on anxiety, mood, self-esteem, and T-cell count in HIV-positive men, Psychol. Rep., 76, 451, 1995.
186. Antoni, M. H. Baggett, L., Ironson, G., LaPerriere, A., August, S., Klimas, N., et al., Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity, J. Consult. Clin. Psychol., 59, 906, 1991.
187. Mulder, C. L., Antoni, M. H., Emmelkamp, P. M., Veugelers, P. J., Sandfort, T. G., van de Vijver, F. A., and de Vries, M. J., Psychosocial group intervention and decline of immunologic parameters in asymptomatic HIV-infected homosexual men, Psychother. Psychosom., 63, 185, 1995.
188. Solomon, G. F. and Temoshok, L., A psychoneuroimmunogotic perspective on AIDS research: questions, preliminary findings, and suggestions, J. Applied Soc. Psychol., 17, 286, 1987.
189. Keet, I. P. M., Krol, A., Klein, M. R., Veugelers, P., de Wit, J., Roos, M., et al., Characteristics of long-term asymptomatic infection with Human Immunodeficiency Virus Type 1 in men with normal and low CD4+ cell counts, J. Infect. Dis., 169, 1236, 1994.
190. Patterson, T. L., Shaw, W. S., Semple, S. J., Cherner, M., McCutchan, A., Atkinson, J. H., et al., Relationship of psychosocial factors to HIV disease progresssion, Ann. Behav. Med., 18, 30, 1996.
191. Halbreich, U., Asnis, G. M., Schindledecker, R., Zurnoff, B., and Nathan, R. S., Cortisol secretion in endogenous depression, I: Basal plasma levels, Arch. Gen. Psychiatry, 42, 909, 1985.
192. Linkowski, P., Mendelwicz, J., Kerkhofs, M., LeClercq, R., Goldstein, J., Brasseur, M., et al., 24 hour profiles of ACTH, cortisol and growth hormone in major depressive illness: Effect of antidepressant treatment, J. Clin. Endocrinol. Metab., 65, 141, 1987.
193. Mann, J. J., Brown, R. P., Halper, J. P., Sweeney, J. A., Kocsis, J. H., Stokes, P. E., and Bilezikian, J. P., Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation, N. Engl. J. Med., 313, 715, 1985.
194. Stein, M., Miller, A. H., and Trestman, R. L., Depression and the immune system, in Psychoneuroimmunology, Ader, R., Felten, D. L., and Cohen, N., Eds., Academic Press, San Diego, 1991.
195. Herbert, T. B. and Cohen, S., Depression and immunity: a meta-analytic review, Psychol. Bull., 113, 472, 1993.
196. Maes, M., Stevens, W. J., Declerck, L. S., Bridts, C. H., Peeters, D., Schotte, C., and Cosyns, P., Significantly increased expression of T-cell activation markers (interleukin 2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 17, 241, 1993.
197. Lyketsos, C. G., Hoover, D. R., Guccione, M., Senterfitt, W., Dew, M. A., Wesch, J., et al., Depressive symptoms as predictors of medical outcomes in HIV infection, JAMA, 270, 2563, 1993.
198. Burack, J. H., Barrett, D. C., Stall, R. D., Chesney, M. A., Ekstrand, M. L., and Coates, T. J., Depressive symptoms and CD4 lymphocyte decline among HIV-infected men, JAMA, 270, 2568, 1993.
199. Rabkin, J. G., Wagner, G., and Rabkin, R., Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial, J. Clin. Psychiatry, 55, 433, 1994.
200. Rabkin, J. G., Rabkin, R., Harrison, W., and Wagner, G., Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness, Am. J. Psychiatry, 151, 516, 1994.
201. Rabkin, J. G., Rabkin, R., and Wagner, G., Effects of fluoxetine on mood and immune status in depressed patients with HIV disease, J. Clin. Psychiatry, 55, 92, 1994.
202. Drebing, C. E., Van Gorp, W., Hinkin, C., Miller, E. N., Satz, P., Kim, D. S., et al., Confounding factors in the measurement of depression in HIV, J. Personality Assess., 62, 68, 1994.
203. Kirschbaum, C., Klauer, T., Sigrun-Heide, F., and Hellhammer, D. H., Sex-specific effects of social support on cortisol and subjective responses to acute psychological stress, Psychosom. Med., 57, 23, 1995.
204. Lepore, S. J., Mata Allen, K. A., and Evans, G. W., Social support lowers cardiovascular reactivity to an acute Stressor, Psychosom. Med., 55, 518, 1993.
205. Hofer, M., Relationships as regulators: a psychobiologic perspective on bereavement, Psychosom. Med., 36, 363, 1974.
206. Berkman, L., The role of social relations in health promotion, Psychosom. Med., 57, 245, 1995.
207. Theorell, T., Blomkvist, V., Jonsson, H., Schulman, S., Berntrop, E., and Stigendal, L., Social support and the development of immune function in human immunodeficiency virus infection, Psychosom. Med., 57, 32, 1995.
208. Persson, L., Gullberg, B., Hanson, B. S., Moestrup, T., and Ostergreen, P. O., Influences of social network and social support on the development of the CD4-lymphocyte level - a prospective population study of HIV-infected homo- and bi-sexual men in Malmo, Sweden, paper presented at the Second International Conference on Psychosocial Aspects of AIDS, Brighton, U.K., 1994.
209. Persson, L., Gullberg, B., Hanson, B. S., Moestrup, T., and Ostergren, P. O., HIV infection: social network, social support, and CD4 lymphocyte values in infected homosexual men in Malmo, Sweden, J. Epidemiol. Comm. Health, 48, 580, 1994.
210. Miller, G. E., Kemeny, M. E., Taylor, S. E., Cole, S. W., and Visscher, B. R., Social relationships and immune processes in HIV seropositive gay men, Ann. Behav. Med., in press.
211. Blomkvist, V., Theorell, T., Jonsson, H., Schulman, S., Berntorp, E., and Stiegendal, L., Psychosocial self-prognosis in relation to mortality and morbidity in hemophiliacs with HIV infection, Psychother. Psychosom., 62, 185, 1994.
212. Coe, C. L., Psychosocial factors and immunity in nonhuman primates: a review, Psychosom. Med., 55, 298, 1993.
213. Capitanio, J. P. and Lerche, N. W., Psychosocial factors and disease progression in simian AIDS: a preliminary report, AIDS, 5, 1103, 1991.
214. Capitanio, J. P., Mendoza, S. P., and Lerche, N. W., Affiliation and agonism influence pituitaryadrenal activity and SIV disease progression in male rhesus macaques, presented to the Scientific Conference of the Psychoneuroimmunology Research Society, Santa Monica CA, 1996.
215. Pennebaker, J. W. and Chew, C. H., Behavioral inhibition and electrodermal activity during deception, J. Pers. Soc. Psychol., 49, 1427, 1985.
216. Gross, J. J. and Levenson, R. W., Emotional suppression: physiology, self-report, and expressive behavior, J. Pers. Soc. Psychol., 64, 970, 1993.
217. Petrie, K. J., Booth, R. J., Pennebaker, J. W., Davison, K. P., and Thomas, M. G., Disclosure of trauma and immune response to a hepatitis B vaccination program, J. Consult. Clin. Psychol., 63, 787, 1995.
218. Pennebaker, J. W., Kiecolt-Glaser, J. K., and Glaser, R., Disclosure of traumas and immune function: health implications for psychotherapy, J. Consult. Clin. Psychol., 56, 239, 1988.
219. Esterling, B. A., Antoni, M. H., Fletcher, M. A., Margulies, S., and Schneiderman, H., Emotional disclosure through writing or speaking modulates latent Epstein-Barr virus reactivation, J. Consult Clin. Psychol., 62, 130, 1994.
220. Totman, R., Kiff, J. Reed, S. A., and Craig, J. W., Predicting experimental colds in volunteers from different measures of recent life stress, J. Psychosom. Res., 24, 155, 1980.
221. Broadbent, D. E., Broadbent, M. H. P., Phillpotts, R. J., and Wallace, J., Some further studies on the prediction of experimental colds in volunteers by psychological factors, J. Psychosom. Res., 28, 511, 1984.
222. Kagan, J., Snidman, N., Julia-Sellers, M., and Johnson, M. O., Temperament and allergic symptoms, Psychosom. Med., 53, 322, 1991.
223. Kagan, J., Reznick, J. S., and Snidman, N., Biological bases of childhood shyness, Science, 240, 167, 1988.
224. Block, J., A study of affective responsiveness in a liedetection situation, J. Pers. Soc. Psychol., 55, 11, 1957.
225. Petito, J. M., Lysle, D. T., Gariepy, J.-L., and Lewis, M. H., Association of genetic differences in social behavior and cellular immune responsiveness: effects of social experience, Brain, Behav. Immun., 8, 111, 1994.
226. Suomi, S. J., Uptight and laid-back monkeys: individual differences in the response to social challenges, in Plasticity of Development, Branch, S., Hall, W., and Dooling, E., Eds., MIT Press, Cambridge, MA, 1991.
227. Cole, S. W., Kemeny, M. E., Taylor, S. E., Visscher, B. R., and Fahey, J. L., Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity, Psychosom. Med., 58, 219, 1996.
228. Cole, S. W., Kemeny, M. E., and Taylor, S. E., Social identity and physical health: Accelerated HIV progression in rejection sensitive gay men, J. Pers. Soc. Psychol., in press.
229. Cole, S. W., Kemeny, M. E., Taylor, S. E., and Visscher, B. R., Elevated physical health risk in gay men who conceal their homosexual identity, Health Psychol., 15, 243, 1996.
230. Kagan, J., Galen 's Prophecy: Temperament in Human Nature, Basic Books, New York, 1994.
231. Gray, J. A., The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septohippocampal System, Oxford University Press, Oxford, 1982.
232. Kraemer, H. C. and Thiemann, S., How Many Subjects? Statistical Power Analysis in Research, Sage, Newbury Park, CA, 1987.
233. Fleming, T. R., Surrogate markers in AIDS and cancer trials, Stat. in Med., 13, 1423, 1994.
234. Taylor, J. M. G., Fahey, J. L., Detels, R., and Giorgi, J. V., CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use; J. Acquir. Immune Defic. Syndr., 2, 114, 1989.
235. Tsiatis, A. A., Dafni, U., DeGruttola, V., Propert, K. J., Strawderman, R. L., and Wulfsohn, M., The relationship of CD4 counts over time to survival in patients with AIDS: is CD4 a good surrogate marker? In AIDS Epidemiology: Methodological Issues, Jewell, N. P., Dietz, K., and Farewell, V. T., Eds., Birkhauser, Boston, MA, 1992.
236. Raboud, J. M., Haley, L., Montaner, J. S., Murphy, C., Januszewska, M., and Schechter, M. T., Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts in clinically stable HIV-infected individuals, J. Acquir. Immune Defic. Syndr., 10, S67, 1995.
237. Park, L. P., Margolick, J. B., Giorgi, J. V., Ferbas, J., Bauer, K., Kaslow, R., and Munoz, A., Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men, J. Acquir. Immune Defic. Syndr., 5, 1124, 1992.
238. Phillips, A. N., Lee, C. A., Elford, J., Janossy, G., and Kernoff, P. B., The cumulative risk of AIDS as the CD4 lymphocyte count declines, J. Acquir. Immune Defic. Syndr., 5, 148, 1992.
239. Kemeny, M. E., Stressful events, psychological responses, and progression of HIV infection, in Handbook of Human Stress and Immunity, Glaser, R. and Kiecolt-Glaser, J. K., Eds., Academic Press, New York, 1994.
240. Kiecolt-Glaser, J. K. and Glaser, R., Methodological issues in behavioral immunology research with humans, Brain, Behav. Immunity, 2, 67, 1988.
241. Adler, N. E., Boyce, T., Chesney, M. A., Cohen, S., Folkman, S., Kahn, R. L., and Syme, S. L., Socioeconomic status and health: the challenge of the gradient, Am. Psychol., 49, 15, 1994.